期刊
VIROLOGY
卷 500, 期 -, 页码 1-10出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.virol.2016.10.008
关键词
Influenza A virus; Canine influenza virus; Inactivated influenza vaccines; Live-attenuated influenza vaccines; Non-structural protein 1; Canine tracheal explant; Reverse genetics; NS1 deficient influenza viruses
类别
资金
- University of Rochester Technology Development Fund
- Horserace Betting Levy Board
- Medical Research Council of the United Kingdom [MC_UU_120/14/9]
- MRC [MC_UU_12014/9] Funding Source: UKRI
Canine Influenza Virus (CIV) H3N8 is the causative agent of canine influenza, a common and contagious respiratory disease of dogs. Currently, only inactivated influenza vaccines (IIVs) are available for the prevention of CIV H3N8. However, live-attenuated influenza vaccines (LAIVs) are known to provide better immunogenicity and protection efficacy than IIVs. Influenza NS1 is a virulence factor that offers an attractive target for the preparation of attenuated viruses as LAIVs. Here we generated recombinant H3N8 CIVs containing truncated or a deleted NS1 protein to test their potential as LAIVs. All recombinant viruses were attenuated in mice and showed reduced replication in cultured canine tracheal explants, but were able to confer complete protection against challenge with wild-type CIV H3N8 after a single intranasal immunization. Immunogenicity and protection efficacy was better than that observed with an IIW. This is the first description of a LAIV for the prevention of H3N8 CIV in dogs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据